Catalyst Wire Dossier Catalyst Wire Dossier

Loteprednol 0.2%

loteprednol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol 0.2%, covering 2023-01-04 to 2023-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization [Phase 3]

See pricing